Kenneth E. Sherman, MD,PhD

Baum, Marianna K; Tamargo, Javier A; Ehman, Richard L; Sherman, Kenneth E; Chen, Jun; Liu, Qingyun; Mandler, Raul N; Teeman, Colby; Martinez, Sabrina S; Campa, Adriana 2021. Heroin use is associated with liver fibrosis in the Miami Adult Studies on HIV (MASH) cohort. Drug and alcohol dependence, 220 , 108531

Jose, Arun; Shah, Shimul A; Anwar, Nadeem; Jones, Courtney R; Sherman, Kenneth E; Elwing, Jean M 2021. Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, ,

Kong, Ling; Karns, Rebekah; Shata, Mohamed Tarek M; Brown, Jennifer L; Lyons, Michael S; Sherman, Kenneth E; Blackard, Jason T 2021. The synthetic opioid fentanyl enhances viral replication in vitro. PloS one, 16 4, e0249581

Sherman, Kenneth E; Kottilil, Shyam; Rouster, Susan D; Abdel-Hameed, Enass A; Boyce, Ceejay L; Meeds, Heidi L; Terrault, Norah; Shata, M Tarek 2021. Hepatitis E Infection in a Longitudinal Cohort of HCV and HCV/HIV Coinfected Persons. AIDS research and human retroviruses, ,

Sherman, Kenneth E; Meeds, Heidi L; Rouster, Susan D; Abdel-Hameed, Enass A; Hernandez, Jacqueline; Tamargo, Javier; Chen, Jun; Ehman, Richard L; Baum, Marianna 2021. Soluble CD163 Identifies Those at Risk for Increased Hepatic Inflammation & Fibrosis. Open forum infectious diseases, 8 6, ofab203

Sherman, Kenneth E; Rouster, Susan D; Meeds, Heidi; Tamargo, Javier; Chen, Jun; Ehman, Richard; Baum, Marianna 2021. PNPLA3 Single Nucleotide Polymorphism Prevalence and Association with Liver Disease in a Diverse Cohort of Persons Living with HIV. Biology, 10 3,

Tamargo, Javier A; Hernandez-Boyer, Jacqueline; Teeman, Colby; Martin, Haley R; Huang, Yongjun; Johnson, Angelique; Campa, Adriana; Martinez, Sabrina S; Li, Tan; Rouster, Susan D; Meeds, Heidi L; Sherman, Kenneth E; Baum, Marianna K 2021. Immune activation: A link between food insecurity and chronic disease in people living with HIV. The Journal of infectious diseases, ,

Tamargo, Javier A; Meade, Christina S; Campa, Adriana; Martinez, Sabrina S; Li, Tan; Sherman, Kenneth E; Baum, Marianna K 2021. Food Insecurity and Cognitive Impairment in the Miami Adult Studies on HIV (MASH) Cohort. The Journal of nutrition, 151 4, 979-986

Tamargo, Javier A; Sherman, Kenneth E; Campa, Adriana; Martinez, Sabrina S; Li, Tan; Hernandez, Jacqueline; Teeman, Colby; Mandler, Raul N; Chen, Jun; Ehman, Richard L; Baum, Marianna K 2021. Food insecurity is associated with magnetic resonance-determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV. The American journal of clinical nutrition, 113 3, 593-601

Abdel-Hameed, Enass A; Rouster, Susan D; Kottilil, Shyam; Sherman, Kenneth E 2020. The enhanced liver fibrosis (ELF)-Index predicts hepatic fibrosis superior to FIB4 and APRI in HIV/HCV infected patients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Bari, Khurram; Shah, Shimul A; Kaiser, Tiffany E; Cohen, Robert M; Anwar, Nadeem; Kleesattel, David; Sherman, Kenneth E 2020. Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a trial. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, ,

Butt, Adeel A; Yan, Peng; Aslam, Samia; Abou-Samra, Abdul-Badi; Sherman, Kenneth E; Shaikh, Obaid S 2020. Liver Fibrosis Progression and Mortality in Hepatitis B- and C-Coinfected Persons Treated With Directly Acting Antiviral Agents: Results From ERCHIVES. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 3, 664-666

Butt, Adeel A; Yan, Peng; Aslam, Samia; Sherman, Kenneth E; Siraj, Dawd; Safdar, Nasia; Hameed, Bilal 2020. Hepatitis C virologic response in hepatitis B and C coinfected persons treated with directly acting antiviral agents: Results from ERCHIVES. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 92 , 184-188

Butt, Adeel Ajwad; Yan, Peng; Shaikh, Obaid S; Lo Re, Vincent; Abou-Samra, Abdul-Badi; Sherman, Kenneth E 2020. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study. Journal of hepatology, 73 2, 277-284

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Alloway, Rita R; Sherman, Kenneth E 2020. Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients. American journal of kidney diseases : the official journal of the National Kidney Foundation, 75 6, 857-867

Gentene, Anthony J; Bell, Allison M; Pence, Alicia; Thomas, Kelly; Jakubecz, Collin; Stacy, Elizabeth; Woolf, Brittany; Guido, Maria Rose; Mueller, Eric W; Sherman, Kenneth E 2020. Sustained Virologic Response of Patients Hospitalized Compared With Those Not Hospitalized During Treatment for Hepatitis C Virus With Direct-Acting Antivirals. The Annals of pharmacotherapy, , 1060028020964117

Seth, Aradhna; Sherman, Kenneth E 2020. Editorial: HCV Cure is the Start of the End For Those With Advanced Fibrosis/Cirrhosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ,

Seth, Aradhna; Sherman, Kenneth E 2020. Hepatitis E: What We Think We Know. Clinical liver disease, 15 Suppl 1, S37-S44

Sherman, Kenneth E; Abdel-Hameed, Enass A; Ehman, Richard L; Rouster, Susan D; Campa, Adriana; Martinez, Sabrina Sales; Huang, Yongjun; Zarini, Gustavo G; Hernandez, Jacqueline; Teeman, Colby; Tamargo, Javier; Liu, Qingyun; Mandler, Raul; Baum, Marianna K 2020. Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index. Digestive diseases and sciences, 65 4, 1252-1257

Sise, Meghan E; Goldberg, David S; Kort, Jens J; Schaubel, Douglas E; Alloway, Rita R; Durand, Christine M; Fontana, Robert J; Brown, Robert S; Friedewald, John J; Prenner, Stacey; Landis, J Richard; Fernando, Melissa; Phillips, Caitlin C; Woodle, E Steve; Rike-Shields, Adele; Sherman, Kenneth E; Elias, Nahel; Williams, Winfred W; Gustafson, Jenna L; Desai, Niraj M; Barnaba, Brittany; Norman, Silas P; Doshi, Mona; Sultan, Samuel T; Aull, Meredith J; Levitsky, Josh; Belshe, Dianne S; Chung, Raymond T; Reese, Peter P 2020. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection. Journal of the American Society of Nephrology : JASN, ,

Zarini, Gustavo; Sales Martinez, Sabrina; Campa, Adriana; Sherman, Kenneth; Tamargo, Javier; Hernandez Boyer, Jacqueline; Teeman, Colby; Johnson, Angelique; Degarege, Abraham; Greer, Pedro; Liu, Qingyun; Huang, Yongjun; Mandler, Raul; Choi, David; Baum, Marianna K 2020. Sex Differences, Cocaine Use, and Liver Fibrosis Among African Americans in the Miami Adult Studies on HIV Cohort. Journal of women's health (2002), ,

Blackard, Jason T; Kong, Ling; Rouster, Susan D; Karns, Rebekah; Horn, Paul S; Kottilil, Shyam; Shata, M Tarek; Sherman, Kenneth E 2019. CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro. PloS one, 14 10, e0224523

Blackard, Jason T; Kwara, Awewura; Sherman, Kenneth E 2019. In response to identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients. Journal of hepatology, 71 6, 1259-1260

Dao, Ann; Cuffy, Madison; Kaiser, Tiffany E; Loethen, Ashley; Cafardi, John; Luckett, Keith; Rike, Adele Helen; Cardi, Michael; Alloway, Rita R; Govil, Amit; Diwan, Tayyab; Sherman, Kenneth E; Shah, Shimul A; Woodle, Ervin Steve 2019. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool. Clinical transplantation, 33 7, e13598

Eckman, Mark H; Ward, John W; Sherman, Kenneth E 2019. Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17 5, 930-939.e9

Farooq, Priya D; Sherman, Kenneth E 2019. Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV. Current HIV/AIDS reports, 16 5, 395-403

Foster, Graham R; Dore, Gregory J; Wang, Stanley; Grebely, Jason; Sherman, Kenneth E; Baumgarten, Axel; Conway, Brian; Jackson, Daniel; Asselah, Tarik; Gschwantler, Michael; Tomasiewicz, Krzysztof; Aguilar, Humberto; Asatryan, Armen; Hu, Yiran; Mensa, Federico J 2019. Glecaprevir/pibrentasvir in patients with chronic HCV and recent drug use: An integrated analysis of 7 phase III studies. Drug and alcohol dependence, 194 , 487-494

Hu, Ke-Qin; Cui, Wei; Rouster, Susan D; Sherman, Kenneth E 2019. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals. World journal of hepatology, 11 5, 442-449

Narayanan, Shivakumar; Abutaleb, Ameer; Sherman, Kenneth E; Kottilil, Shyam 2019. Clinical features and determinants of chronicity in hepatitis E virus infection. Journal of viral hepatitis, 26 4, 414-421

Seth, Aradhna; Sherman, Kenneth E 2019. Fatty liver disease in persons with HIV infection. Topics in antiviral medicine, 27 2, 75-82

Shata, Mohamed Tarek M; Abdel-Hameed, Enass A; Rouster, Susan D; Yu, Li; Liang, Meina; Song, Esther; Esser, Mark T; Shire, Norah; Sherman, Kenneth E 2019. HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles. Pathogens & immunity, 4 1, 39-65

Sherman, Kenneth E; Abdel-Hameed, Enass; Rouster, Susan D; Shata, Mohamed Tarek M; Blackard, Jason T; Safaie, Parham; Kroner, Barbara; Preiss, Liliana; Horn, Paul S; Kottilil, Shyam 2019. Improvement in Hepatic Fibrosis Biomarkers Associated With Chemokine Receptor Inactivation Through Mutation or Therapeutic Blockade. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 68 11, 1911-1918

Sherman, Kenneth E; Peters, Marion G; Thomas, David L 2019. HIV and the liver. Topics in antiviral medicine, 27 3, 101-110

Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X; Aliota, Matthew T; Blackard, Jason T; Dean, Gary E 2019. Zika virus replication and cytopathic effects in liver cells. PloS one, 14 3, e0214016

Abdel-Hameed, Enass A; Rouster, Susan D; Boyce, Ceejay L; Zhang, Xiang; Biesiada, Jacek; Medvedovic, Mario; Sherman, Kenneth E 2018. Ultra-Deep Genomic Sequencing of HCV NS5A Resistance-Associated Substitutions in HCV/HIV Coinfected Patients. Digestive diseases and sciences, 63 3, 645-652

Abutaleb, Ameer; Sherman, Kenneth E 2018. A changing paradigm: management and treatment of the HCV/HIV-co-infected patient. Hepatology international, 12 6, 500-509

Anwar, Nadeem; Sherman, Kenneth E 2018. Transplanting organs from hepatitis B positive donors: Is it safe? Is it ethical? Journal of viral hepatitis, 25 10, 1110-1115

Bari, Khurram; Luckett, Keith; Kaiser, Tiffany; Diwan, Tayyab; Cuffy, Madison; Schoech, Michael R; Safdar, Kamran; Blackard, Jason T; Apewokin, Senu; Paterno, Flavio; Sherman, Kenneth E; Zucker, Stephen D; Anwar, Nadeem; Shah, Shimul A 2018. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients. Hepatology (Baltimore, Md.), 67 5, 1673-1682

Blackard, Jason T; Sherman, Kenneth E 2018. Hepatitis B virus (HBV) reactivation-The potential role of direct-acting agents for hepatitis C virus (HCV). Reviews in medical virology, 28 4, e1984

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Paterno, Flavio; Sherman, Kenneth E 2018. Transplanting Hepatitis C Virus-Infected or Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients. Annals of internal medicine, 169 12, 898-899

Eckman, Mark H; Woodle, E Steve; Thakar, Charuhas V; Paterno, Flavio; Sherman, Kenneth E 2018. Transplanting Hepatitis C Virus-Infected Versus Uninfected Kidneys Into Hepatitis C Virus-Infected Recipients: A Cost-Effectiveness Analysis. Annals of internal medicine, 169 4, 214-223

Rockstroh, Jürgen K; Lacombe, Karine; Viani, Rolando M; Orkin, Chloe; Wyles, David; Luetkemeyer, Anne F; Soto-Malave, Ruth; Flisiak, Robert; Bhagani, Sanjay; Sherman, Kenneth E; Shimonova, Tatiana; Ruane, Peter; Sasadeusz, Joseph; Slim, Jihad; Zhang, Zhenzhen; Samanta, Suvajit; Ng, Teresa I; Gulati, Abhishek; Kosloski, Matthew P; Shulman, Nancy S; Trinh, Roger; Sulkowski, Mark 2018. Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 67 7, 1010-1017

Safaie, Parham; Razeghi, Sanam; Rouster, Susan D; Privitera, Isaac; Sherman, Kenneth E 2018. Hepatitis D diagnostics:Utilization and testing in the United States. Virus research, 250 , 114-117

Sherman, Kenneth E; Rouster, Susan D; Kang, Minhee; Umbleja, Triin; Sterling, Richard; Butt, Adeel A 2018. PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals. Digestive diseases and sciences, 63 11, 2969-2974

Sherman, Kenneth E; Rouster, Susan D; Kong, Ling X; Shata, Tarek M; Archampong, Timothy; Kwara, Awewura; Aliota, Matthew T; Blackard, Jason T 2018. Zika Virus Exposure in an HIV-Infected Cohort in Ghana. Journal of acquired immune deficiency syndromes (1999), 78 5, e35-e38

Sherman, Kenneth E; Shah, Vijay H 2018. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia. Gastroenterology, 154 3, 453-456

Shive, Carey L; Judge, Chelsey J; Clagett, Brian; Kalayjian, Robert C; Osborn, Melissa; Sherman, Kenneth E; Fichtenbaum, Carl; Gandhi, Rajesh T; Kang, Minhee; Popkin, Daniel L; Sieg, Scott F; Lederman, Michael M; Rodriguez, Benigno; Anthony, Donald D 2018. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine, 36 4, 453-460

Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D; Liu, Lin; Li, Eric; Zhao, Lisa; Lim, Joseph K; Morelli, Giuseppe; Kuo, Alexander; Levitsky, Josh; Sherman, Kenneth E; Frazier, Lynn M; Ramani, Ananthakrishnan; Peter, Joy; Akuskevich, Lucy; Fried, Michael W; Nelson, David R 2018. Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Scientific reports, 8 1, 3199

Abdel-Hameed, Enass A; Rouster, Susan D; Zhang, Xiang; Chen, Jing; Medvedovic, Mario; Goodman, Zachary D; Sherman, Kenneth E 2017. Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep Sequence Analysis: Relationship with Hepatic Fibrosis. Journal of acquired immune deficiency syndromes (1999), 74 3, 353-358

Butt, A A; Ren, Y; Marks, K; Shaikh, O S; Sherman, K E 2017. Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES. Alimentary pharmacology & therapeutics, 45 1, 150-159

Judge, Chelsey J; Kostadinova, Lenche; Sherman, Kenneth E; Butt, Adeel A; Falck-Ytter, Yngve; Funderburg, Nicholas T; Landay, Alan L; Lederman, Michael M; Sieg, Scott F; Sandberg, Johan K; Anthony, Donald D 2017. CD56bright NK IL-7R? expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections. Journal of leukocyte biology, 102 1, 171-184

Kiser, Jennifer J; Lu, Darlene; Rosenkranz, Susan L; Morse, Gene D; DiFrancesco, Robin; Sherman, Kenneth E; Butt, Adeel A 2017. Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s. Drugs in R&D, 17 4, 557-567

Murrison, Liza Bronner; Sherman, Kenneth E 2017. The Enigma of Hepatitis E Virus. Gastroenterology & hepatology, 13 8, 484-491

Ragni, Margaret V; Humar, Abhinav; Stock, Peter G; Blumberg, Emily A; Eghtesad, Bijan; Fung, John J; Stosor, Valentina; Nissen, Nicholas; Wong, Michael T; Sherman, Kenneth E; Stablein, Donald M; Barin, Burc 2017. Hemophilia Liver Transplantation Observational Study. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 23 6, 762-768

Sherman, Kenneth E; Kang, Minhee; Sterling, Richard; Umbleja, Triin; Marks, Kristen; Kiser, Jennifer J; Alston-Smith, Beverly; Greaves, Wayne; Butt, Adeel A; The Actg Birth Study Team, 2017. Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World journal of hepatology, 9 4, 217-223

Sherman, Kenneth E; Peters, Marion G; Thomas, David 2017. Human immunodeficiency virus and liver disease: A comprehensive update. Hepatology communications, 1 10, 987-1001

Soriano, Vincent; Sherman, Kenneth E; Barreiro, Pablo 2017. Hepatitis delta and HIV infection. AIDS (London, England), 31 7, 875-884

Abdel-Hameed, Enass A; Rouster, Susan D; Ji, Hong; Ulm, Ashley; Hetta, Helal F; Anwar, Nadeem; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Evaluating the Role of Cellular Immune Responses in the Emergence of HCV NS3 Resistance Mutations During Protease Inhibitor Therapy. Viral immunology, 29 4, 252-8

Blackard, Jason T; Ma, Gang; Polen, Clarissa; DuBois, Juwen C; Gast, Jonathon; Radens, Caleb M; Sterling, Richard K; Sherman, Kenneth E 2016. Recombination among GB virus C (GBV-C) isolates in the United States. The Journal of general virology, 97 7, 1537-1544

Butt, A A; Yan, P; Marks, K; Shaikh, O S; Sherman, K E 2016. Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES. Alimentary pharmacology & therapeutics, 44 7, 728-37

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Chung, Raymond T; Sherman, Kenneth E 2016. Treatment adherence and virological response rates in hepatitis C virus infected persons treated with sofosbuvir-based regimens: results from ERCHIVES. Liver international : official journal of the International Association for the Study of the Liver, 36 9, 1275-83

Butt, Adeel A; Yan, Peng; Shaikh, Obaid S; Chung, Raymond T; Sherman, Kenneth E 2016. Sofosbuvir-based regimens in clinical practice achieve SVR rates closer to clinical trials: results from ERCHIVES. Liver international : official journal of the International Association for the Study of the Liver, 36 5, 651-8

Campa, Adriana; Martinez, Sabrina Sales; Sherman, Kenneth E; Greer, Joe Pedro; Li, Yinghui; Garcia, Stephanie; Stewart, Tiffanie; Ibrahimou, Boubakari; Williams, O Dale; Baum, Marianna K 2016. Cocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort. Journal of drug abuse, 2 4,

Feld, Jordan J; Maan, Raoel; Zeuzem, Stefan; Kuo, Alexander; Nelson, David R; Di Bisceglie, Adrian M; Manns, Michael P; Sherman, Ken; Frazier, Lynn M; Sterling, Richard; Mailliard, Mark; Schmidt, Monica; Akushevich, Lucy; Vainorius, Monika; Fried, Michael W 2016. Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 63 6, 776-783

Hetta, Helal F; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; Medhat, Ahmed; Nassar, Mahmoud I; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis. Journal of medical microbiology, 65 8, 703-712

Judge, Chelsey J; Sandberg, Johan K; Funderburg, Nicholas T; Sherman, Kenneth E; Butt, Adeel A; Kang, Minhee; Landay, Alan L; Lederman, Michael M; Anthony, Donald D 2016. Brief Report: CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. Journal of acquired immune deficiency syndromes (1999), 73 3, 258-262

Lyons, Michael S; Kunnathur, Vidhya A; Rouster, Susan D; Hart, Kimberly W; Sperling, Matthew I; Fichtenbaum, Carl J; Sherman, Kenneth E 2016. Prevalence of Diagnosed and Undiagnosed Hepatitis C in a Midwestern Urban Emergency Department. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 62 9, 1066-71

Mehta, Minesh; Hetta, Helal F; Abdel-Hameed, Enass A; Rouster, Susan D; Hossain, MdMonir; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; El-Mokhtar, Mohamed A; Abdelwahab, Sayed F; Medhat, Ahmed; Sherman, Kenneth E; Shata, Mohamed Tarek M 2016. Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients. Archives of virology, 161 11, 3161-9

Reau, Nancy; Fried, Michael W; Nelson, David R; Brown, Robert S; Everson, Gregory T; Gordon, Stuart C; Jacobson, Ira M; Lim, Joseph K; Pockros, Paul J; Reddy, K Rajender; Sherman, Kenneth E 2016. HCV Council--critical appraisal of data: recommendations for clinical practice in a rapidly evolving therapeutic landscape. Liver international : official journal of the International Association for the Study of the Liver, 36 4, 488-502

Sherman, K E; Ke, R; Rouster, S D; Abdel-Hameed, E A; Park, C; Palascak, J; Perelson, A S 2016. Viral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacs. Haemophilia : the official journal of the World Federation of Hemophilia, 22 4, 543-8

Butt, A A; Yan, P; Shaikh, O S; Freiberg, M S; Lo Re, V; Justice, A C; Sherman, K E 2015. Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings. Journal of viral hepatitis, 22 9, 691-700

Butt, Adeel A; Yan, Peng; Lo Re, Vincent; Rimland, David; Goetz, Matthew B; Leaf, David; Freiberg, Matthew S; Klein, Marina B; Justice, Amy C; Sherman, Kenneth E 2015. Liver fibrosis progression in hepatitis C virus infection after seroconversion. JAMA internal medicine, 175 2, 178-85

Hetta, Helal F; Mekky, Mohamed A; Khalil, Nasr K; Mohamed, Wegdan A; El-Feky, Mohamed A; Ahmed, Shabaan H; Daef, Enas A; Nassar, Mahmoud I; Medhat, Ahmed; Sherman, Kenneth E; Shata, Mohamed Tarek M 2015. Association of colonic regulatory T cells with hepatitis C virus pathogenesis and liver pathology. Journal of gastroenterology and hepatology, 30 10, 1543-51

Jensen, Donald; Sherman, Kenneth E; Hézode, Christophe; Pol, Stanislas; Zeuzem, Stefan; de Ledinghen, Victor; Tran, Albert; Elkhashab, Magdy; Younes, Ziad H; Kugelmas, Marcelo; Mauss, Stefan; Everson, Gregory; Luketic, Velimir; Vierling, John; Serfaty, Lawrence; Brunetto, Maurizia; Heo, Jeong; Bernstein, David; McPhee, Fiona; Hennicken, Delphine; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie 2015. Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders. Journal of hepatology, 63 1, 30-7

Sherman, Kenneth E; Rockstroh, Juergen; Thomas, David 2015. Human immunodeficiency virus and liver disease: An update. Hepatology (Baltimore, Md.), 62 6, 1871-82

Shire, Norah J; Sherman, Kenneth E 2015. Epidemiology of Hepatitis C Virus: A Battle on New Frontiers. Gastroenterology clinics of North America, 44 4, 699-716

Wyles, David L; Ruane, Peter J; Sulkowski, Mark S; Dieterich, Douglas; Luetkemeyer, Anne; Morgan, Timothy R; Sherman, Kenneth E; Dretler, Robin; Fishbein, Dawn; Gathe, Joseph C; Henn, Sarah; Hinestrosa, Federico; Huynh, Charles; McDonald, Cheryl; Mills, Anthony; Overton, Edgar Turner; Ramgopal, Moti; Rashbaum, Bruce; Ray, Graham; Scarsella, Anthony; Yozviak, Joseph; McPhee, Fiona; Liu, Zhaohui; Hughes, Eric; Yin, Philip D; Noviello, Stephanie; Ackerman, Peter 2015. Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1. The New England journal of medicine, 373 8, 714-25

Abdel-Hameed, Enass A; Ji, Hong; Sherman, Kenneth E; Shata, Mohamed T M 2014. Epigenetic modification of FOXP3 in patients with chronic HIV infection. Journal of acquired immune deficiency syndromes (1999), 65 1, 19-26

Anwar, Nadeem; Sherman, Kenneth E 2014. HCV treatment of special populations: HIV coinfected, liver transplant, and renal failure. Clinical liver disease, 4 4, 80-83

Blackard, Jason T; Ma, Gang; Sengupta, Satarupa; Martin, Christina M; Powell, Eleanor A; Shata, M Tarek; Sherman, Kenneth E 2014. Evidence of distinct populations of hepatitis C virus in the liver and plasma of patients co-infected with HIV and HCV. Journal of medical virology, 86 8, 1332-41

Lin, M V; Charlton, A N; Rouster, S D; Zamor, P J; Sherman, K E 2014. Hepatitis C virus NS3 mutations in haemophiliacs. Haemophilia : the official journal of the World Federation of Hemophilia, 20 5, 659-65

Schmidt, Warren N; Nelson, David R; Pawlotsky, Jean-Michel; Sherman, Kenneth E; Thomas, David L; Chung, Raymond T 2014. Direct-acting antiviral agents and the path to interferon independence. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 12 5, 728-37

Sherman, K E; Terrault, N; Barin, B; Rouster, S D; Shata, M T 2014. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. Journal of viral hepatitis, 21 8, e74-7

Sherman, Kenneth E; Guedj, Jeremie; Shata, Mohamed Tarek; Blackard, Jason T; Rouster, Susan D; Castro, Mario; Feinberg, Judith; Sterling, Richard K; Goodman, Zachary; Aronow, Bruce J; Perelson, Alan S 2014. Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Science translational medicine, 6 246, 246ra98

Sherman, Kenneth E; Thomas, David; Chung, Raymond T 2014. Human immunodeficiency virus and liver disease forum 2012. Hepatology (Baltimore, Md.), 59 1, 307-17

Shata, Mohamed Tarek M; Abdel-Hameed, Enass A; Hetta, Helal F; Sherman, Kenneth E 2013. Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2). Journal of clinical pathology, 66 11, 967-75

Blackard, Jason T; Ma, Gang; Welge, Jeffrey A; Martin, Christina M; Sherman, Kenneth E; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J 2012. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. Journal of medical virology, 84 2, 242-52

Jennings, Carrie L; Sherman, Kenneth E 2012. Hepatitis C and HIV co-infection: new drugs in practice and in the pipeline. Current HIV/AIDS reports, 9 3, 231-7

Kemmer, N; Hua, L; Andersen, J W; Chung, R T; Butt, A A; Sherman, K E 2012. Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study. Journal of viral hepatitis, 19 11, 792-800

Kong, Ling; Cardona Maya, Walter; Moreno-Fernandez, Maria E; Ma, Gang; Shata, Mohamed T; Sherman, Kenneth E; Chougnet, Claire; Blackard, Jason T 2012. Low-level HIV infection of hepatocytes. Virology journal, 9 , 157

Martin, C M; Welge, J A; Rouster, S D; Shata, M T; Sherman, K E; Blackard, J T 2012. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. Journal of viral hepatitis, 19 10, 716-23

Shata, Mohamed T; Daef, Enas A; Zaki, Maysaa E; Abdelwahab, Sayed F; Marzuuk, Naglaa M; Sobhy, Maha; Rafaat, Marwa; Abdelbaki, Liala; Nafeh, Mohamed A; Hashem, Mohamed; El-Kamary, Samer S; Shardell, Michelle D; Mikhail, Nabiel N; Strickland, George T; Sherman, Kenneth E 2012. Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt. Transactions of the Royal Society of Tropical Medicine and Hygiene, 106 10, 613-8

Sherman, Kenneth E 2012. Therapeutic approach to the treatment-naive patient with hepatitis C virus genotype 1 infection: a step-by-step approach. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55 9, 1236-41

Blackard, Jason T; Ma, Gang; Martin, Christina M; Rouster, Susan D; Shata, M Tarek; Sherman, Kenneth E 2011. HIV Variability in the Liver and Evidence of Possible Compartmentalization. AIDS research and human retroviruses, ,

Blackard, Jason T; Welge, Jeffrey A; Taylor, Lynn E; Mayer, Kenneth H; Klein, Robert S; Celentano, David D; Jamieson, Denise J; Gardner, Lytt; Sherman, Kenneth E 2011. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 5, 674-80

Eckman, Mark H; Kaiser, Tiffany E; Sherman, Kenneth E 2011. The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 11, 1294-306

Hernandez, Maria D; Sherman, Kenneth E 2011. HIV/hepatitis C coinfection natural history and disease progression. Current opinion in HIV and AIDS, 6 6, 478-82

Kemmer, Nyingi M; Sherman, Kenneth E 2011. Liver transplantation trends in the HIV population. Digestive diseases and sciences, 56 11, 3393-8

Sherman, Kenneth E 2011. Hepatitis e virus infection: more common than previously realized? Gastroenterology & hepatology, 7 11, 759-61

Sherman, Kenneth E; Flamm, Steven L; Afdhal, Nezam H; Nelson, David R; Sulkowski, Mark S; Everson, Gregory T; Fried, Michael W; Adler, Michael; Reesink, Hendrik W; Martin, Marie; Sankoh, Abdul J; Adda, Nathalie; Kauffman, Robert S; George, Shelley; Wright, Christopher I; Poordad, Fred 2011. Response-guided telaprevir combination treatment for hepatitis C virus infection. The New England journal of medicine, 365 11, 1014-24

Sherman, Kenneth E; Thomas, David L; Chung, Raymond T 2011. Human immunodeficiency virus and liver disease forum 2010: conference proceedings. Hepatology (Baltimore, Md.), 54 6, 2245-53

Taylor, Lynn E; Holubar, Marisa; Wu, Kunling; Bosch, Ronald J; Wyles, David L; Davis, John A; Mayer, Kenneth H; Sherman, Kenneth E; Tashima, Karen T 2011. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 6, 812-8

Blackard, Jason T; Ma, Gang; Limketkai, Berkeley N; Welge, Jeffrey A; Dryer, Peter D; Martin, Christina M; Hiasa, Yoichi; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J; Sherman, Kenneth E 2010. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. Journal of clinical microbiology, 48 11, 4256-9

Kemmer, Nyingi M; Sherman, Kenneth E 2010. Hepatitis C-related arthropathy: Diagnostic and treatment considerations. The Journal of musculoskeletal medicine, 27 9, 351-354

Martin, C M; Welge, J A; Shire, N J; Rouster, S D; Shata, M T; Sherman, K E; Blackard, J T 2010. Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals. Journal of viral hepatitis, 17 8, 588-97

McHutchison, John; Goodman, Zachary; Patel, Keyur; Makhlouf, Hala; Rodriguez-Torres, Maribel; Shiffman, Mitchell; Rockey, Don; Husa, Petr; Chuang, Wan-Long; Levine, Robert; Jonas, Mark; Theodore, Dickens; Brigandi, Richard; Webster, Alison; Schultz, Margaret; Watson, Helen; Stancil, Britt; Gardner, Stephen 2010. Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection. Gastroenterology, 138 4, 1365-73, 1373.e1-2

Rashkin, S; Rouster, S; Goodman, Z D; Sherman, K E 2010. T-helper cells and liver fibrosis in hepatitis C virus-monoinfected patients. Journal of viral hepatitis, 17 3, 222-6

Schmeltzer, Paul; Sherman, Kenneth E 2010. Occult hepatitis B: clinical implications and treatment decisions. Digestive diseases and sciences, 55 12, 3328-35

Sherman, Kenneth E 2010. Thymosin alpha 1 for treatment of hepatitis C virus: promise and proof. Annals of the New York Academy of Sciences, 1194 , 136-40

Sherman, Kenneth E; Andersen, Janet W; Butt, Adeel A; Umbleja, Triin; Alston, Beverly; Koziel, Margaret J; Peters, Marion G; Sulkowski, Mark; Goodman, Zachary D; Chung, Raymond T 2010. Sustained Long-Term Antiviral Maintenance Therapy in HCV/HIV-Coinfected Patients (SLAM-C). Journal of acquired immune deficiency syndromes (1999), ,

Sherman, Kenneth E; Rouster, Susan D; Stanford, Sandra; Blackard, Jason T; Shire, Norah; Koziel, Margaret; Peters, Marion; Chung, Raymond T 2010. Hepatitis C virus (HCV) quasispecies complexity and selection in HCV/HIV-coinfected subjects treated with interferon-based regimens. The Journal of infectious diseases, 201 5, 712-9

Sherman, Kenneth E; Soriano, Vincent; Chung, Raymond T 2010. Human immunodeficiency virus and liver disease: conference proceedings. Hepatology (Baltimore, Md.), 51 3, 1046-54

Sulkowski, Mark S; Shiffman, Mitchell L; Afdhal, Nezam H; Reddy, K Rajender; McCone, Jonathan; Lee, William M; Herrine, Steven K; Harrison, Stephen A; Poordad, F Fred; Koury, Kenneth; Deng, Weiping; Noviello, Stephanie; Pedicone, Lisa D; Brass, Clifford A; Albrecht, Janice K; McHutchison, John G 2010. Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology, 139 5, 1602-11, 1611.e1

Atiq, Muslim; Shire, Norah J; Barrett, Anna; Rouster, Susan D; Sherman, Kenneth E; Shata, Mohamed T 2009. Hepatitis E virus antibodies in patients with chronic liver disease. Emerging infectious diseases, 15 3, 479-81

Blackard, Jason T; Rouster, Susan D; Nady, Soad; Galal, Gehan; Marzuuk, Naglaa; Rafaat, Marwaa M; Daef, Enas; El Din, Salwa Seif; Purcell, Robert H; Emerson, Suzanne U; Sherman, Kenneth E; Shata, M Tarek 2009. Genotypic characterization of symptomatic hepatitis E virus (HEV) infections in Egypt. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 46 2, 140-4

Dryer, Peter D; Limketkai, Berkeley N; Martin, Christina M; Ma, Gang; Sherman, Kenneth E; Taylor, Lynn E; Mayer, Kenneth H; Jamieson, Denise J; Blackard, Jason T 2009. Screening for hepatitis C virus non-nucleotide resistance mutations in treatment-naive women. The Journal of antimicrobial chemotherapy, 64 5, 945-8

Gordon, Stuart C; Sherman, Kenneth E 2009. Treatment of HBV/HCV coinfection: releasing the enemy within. Gastroenterology, 136 2, 393-6

Martin, Christina M; Welge, Jeffrey A; Shire, Norah J; Shata, Mohamed T; Sherman, Kenneth E; Blackard, Jason T 2009. Cytokine expression during chronic versus occult hepatitis B virus infection in HIV co-infected individuals. Cytokine, 47 3, 194-8

Poynard, Thierry; Colombo, Massimo; Bruix, Jordi; Schiff, Eugene; Terg, Ruben; Flamm, Steven; Moreno-Otero, Ricardo; Carrilho, Flair; Schmidt, Warren; Berg, Thomas; McGarrity, Thomas; Heathcote, E Jenny; Gonçales, Fernando; Diago, Moises; Craxi, Antonio; Silva, Marcelo; Bedossa, Pierre; Mukhopadhyay, Pabak; Griffel, Louis; Burroughs, Margaret; Brass, Clifford; Albrecht, Janice 2009. Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. Gastroenterology, 136 5, 1618-28.e2

Sherman, Kenneth; Belkin, Igor M; Friedland, Kevin D; O'Reilly, John; Hyde, Kimberly 2009. Accelerated warming and emergent trends in fisheries biomass yields of the world's large marine ecosystems. Ambio, 38 4, 215-24

Shire, Norah J; Rao, Marepalli B; Succop, Paul; Buncher, C Ralph; Andersen, Janet A; Butt, Adeel A; Chung, Raymond T; Sherman, Kenneth E 2009. Improving noninvasive methods of assessing liver fibrosis in patients with hepatitis C virus/human immunodeficiency virus co-infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 7 4, 471-80, 480.e1-2

Blackard, J T; Sherman, K E 2008. HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver? Journal of viral hepatitis, 15 5, 323-30

Blackard, Jason T; Shata, M Tarek; Shire, Norah J; Sherman, Kenneth E 2008. Acute hepatitis C virus infection: a chronic problem. Hepatology (Baltimore, Md.), 47 1, 321-31

Dichiara, A J; Atkinson, M; Goodman, Z; Sherman, K E 2008. Ciprofloxacin-induced acute cholestatic liver injury and associated renal failure. Case report and review. Minerva gastroenterologica e dietologica, 54 3, 307-15

Kemmer, Nyingi; Sherman, Kenneth E 2008. What is the impact of HIV infection on survival after liver transplantation? Nature clinical practice. Gastroenterology & hepatology, 5 8, 426-7

Alatrakchi, Nadia; Graham, Camilla S; van der Vliet, Hans J J; Sherman, Kenneth E; Exley, Mark A; Koziel, Margaret James 2007. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. Journal of virology, 81 11, 5882-92

Blackard, Jason T; Kang, Minhee; St Clair, J Benjamin; Lin, Wenyu; Kamegaya, Yoshitaka; Sherman, Kenneth E; Koziel, Margaret James; Peters, Marion G; Andersen, Janet; Chung, Raymond T 2007. Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 27 4, 263-9

Blackard, Jason T; Sherman, Kenneth E 2007. Hepatitis C virus coinfection and superinfection. The Journal of infectious diseases, 195 4, 519-24

Shata, M T; Barrett, A; Shire, N J; Abdelwahab, S F; Sobhy, M; Daef, E; El-Kamary, S S; Hashem, M; Engle, R E; Purcell, R H; Emerson, S U; Strickland, G T; Sherman, K E 2007. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. Journal of immunological methods, 328 1-2, 152-61

Sherman, Kenneth E 2007. New paradigms in the management of hepatitis C virus co-infections. Nature clinical practice. Gastroenterology & hepatology, 4 Suppl 1 , S10-6

Sherman, Kenneth E; Fleischer, Russell; Laessig, Katherine; Murray, Jeffrey; Tauber, William; Birnkrant, Debra 2007. Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations. Hepatology (Baltimore, Md.), 46 6, 2014-20

Sherman, Kenneth E; Goodman, Zachary D; Sullivan, Sara T; Faris-Young, Sima 2007. Liver biopsy in cirrhotic patients. The American journal of gastroenterology, 102 4, 789-93

Sherman, Kenneth E; Peters, Marion; Koziel, Margaret James 2007. HIV and liver disease forum: conference proceedings. Hepatology (Baltimore, Md.), 45 6, 1566-77

Shire, N J; Welge, J A; Sherman, K E 2007. Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis. Journal of viral hepatitis, 14 4, 239-48

Shire, Norah J; Rouster, Susan D; Stanford, Sandra D; Blackard, Jason T; Martin, Christina M; Fichtenbaum, Carl J; Sherman, Kenneth E 2007. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), 44 3, 309-14

Atiq, Muslim; Neff, Guy W; Buell, Joseph; Kemmer, Nyingi; Rudich, Steven; Weber, Fred; Sherman, Kenneth 2006. Rhabdomylysis transference during liver transplantation. Transplantation, 81 9, 1359-60

Blackard, Jason T; Kang, Minhee; Sherman, Kenneth E; Koziel, Margaret James; Peters, Marion G; Chung, Raymond T 2006. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 26 11, 834-8

Blackard, Jason T; Kemmer, Nyingi; Sherman, Kenneth E 2006. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology (Baltimore, Md.), 44 1, 15-22

Graham, Camilla S; Wells, Annalee; Liu, Tun; Sherman, Kenneth E; Peters, Marion; Chung, Raymond T; Bhan, Atul K; Andersen, Janet; Koziel, Margaret James 2006. Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection. AIDS (London, England), 20 3, 345-51

Mandac, Jamie C; Chaudhry, Sonal; Sherman, Kenneth E; Tomer, Yaron 2006. The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology (Baltimore, Md.), 43 4, 661-72

Mann, Elizabeth A; Stanford, Sandra; Sherman, Kenneth E 2006. Prevalence of mutations in hepatitis C virus core protein associated with alteration of NF-kappaB activation. Virus research, 121 1, 51-7

Mrus, Joseph M; Sherman, Kenneth E; Leonard, Anthony C; Sherman, Susan N; Mandell, Karen L; Tsevat, Joel 2006. Health values of patients coinfected with HIV/hepatitis C: are two viruses worse than one? Medical care, 44 2, 158-66

Neff, Guy W; Jayaweera, Dushyantha; Sherman, Kenneth E 2006. Drug-Induced Liver Injury in HIV Patients. Gastroenterology & hepatology, 2 6, 430-437

Peters, Marion G; Andersen, Janet; Lynch, Patrick; Liu, Tun; Alston-Smith, Beverly; Brosgart, Carol L; Jacobson, Jeffrey M; Johnson, Victoria A; Pollard, Richard B; Rooney, James F; Sherman, Kenneth E; Swindells, Susan; Polsky, Bruce 2006. Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology (Baltimore, Md.), 44 5, 1110-6

Schwarze-Zander, Carolynne; Blackard, Jason T; Zheng, Hui; Addo, Marylyn M; Lin, Wenyu; Robbins, Gregory K; Sherman, Kenneth E; Zdunek, Dietmar; Hess, Georg; Chung, Raymond T 2006. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. The Journal of infectious diseases, 194 4, 410-9

Shire, N J; Sherman, K E 2006. Management of hepatitis B virus in HIV-positive patients. Minerva gastroenterologica e dietologica, 52 1, 67-87

Shire, Norah J; Horn, Paul S; Rouster, Susan D; Stanford, Sandra; Eyster, M Elaine; Sherman, Kenneth E 2006. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia. Hepatology (Baltimore, Md.), 44 5, 1146-57

Shire, Norah J; Welge, Jeffrey A; Sherman, Kenneth E 2006. Efficacy of inactivated hepatitis A vaccine in HIV-infected patients: a hierarchical bayesian meta-analysis. Vaccine, 24 3, 272-9

Alatrakchi, Nadia; Graham, Camilla S; He, Qi; Sherman, Kenneth E; Koziel, Margaret James 2005. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. The Journal of infectious diseases, 191 5, 702-9

Chun, Sooyun; Sherman, Kenneth E 2005. Treatment of hepatitis C virus/HIV coinfection. Clinics in liver disease, 9 3, 525-33, ix

Glesby, Marshall J; Bassett, Roland; Alston-Smith, Beverly; Fichtenbaum, Carl; Jacobson, Elizabeth L; Brass, Clifford; Owens, Susan; Sulkowski, Mark; Race, Elizabeth M; Sherman, Kenneth E 2005. Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection. The Journal of infectious diseases, 191 5, 686-93

Graham, Camilla S; Wells, Annalee; Liu, Tun; Sherman, Kenneth E; Peters, Marion; Chung, Raymond T; Bhan, Atul K; Andersen, Janet; Koziel, Margaret James 2005. Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS (London, England), 19 8, 767-73

Lienesch, Douglas; Morris, Robert; Metzger, Allan; Debuys, Paige; Sherman, Kenneth 2005. Absence of cyclic citrullinated peptide antibody in nonarthritic patients with chronic hepatitis C infection. The Journal of rheumatology, 32 3, 489-93

Qin, Hongxing; Shire, Norah J; Keenan, Erica D; Rouster, Susan D; Eyster, M Elaine; Goedert, James J; Koziel, Margaret James; Sherman, Kenneth E 2005. HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood, 105 2, 533-41

Sherman, Kenneth E 2005. Treatment of hepatitis C virus and human immunodeficiency virus co-infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 3 10 Suppl 2, S118-21

Sherman, Kenneth E; Shire, Norah J; Cernohous, Paul; Rouster, Susan D; Omachi, Janice H; Brun, Scott; Da Silva, Barbara 2005. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41 8, 1186-95

Sherman, Kenneth E; Shire, Norah J; Rouster, Susan D; Peters, Marion G; James Koziel, Margaret; Chung, Raymond T; Horn, Paul S 2005. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology, 128 2, 313-27

Shire, Norah J; Sherman, Kenneth E 2005. Clinical trials of treatment for hepatitis C virus infection in HIV-infected patients: past, present, and future. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 41 Suppl 1 , S63-8

Shire, Norah J; Sherman, Kenneth E 2005. Management of HBV/HIV-coinfected Patients. Seminars in liver disease, 25 Suppl 1 , 48-57

Blackard, Jason T; Yang, Yijun; Bordoni, Paola; Sherman, Kenneth E; Chung, Raymond T 2004. Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy. The Journal of infectious diseases, 189 8, 1472-81

Chung, Raymond T; Andersen, Janet; Volberding, Paul; Robbins, Gregory K; Liu, Tun; Sherman, Kenneth E; Peters, Marion G; Koziel, Margaret J; Bhan, Atul K; Alston, Beverly; Colquhoun, Dodi; Nevin, Tom; Harb, George; van der Horst, Charles 2004. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. The New England journal of medicine, 351 5, 451-9

Fleischer, Russell; Boxwell, Debra; Sherman, Kenneth E 2004. Nucleoside analogues and mitochondrial toxicity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 38 8, e79-80

Graham, Camilla S; Curry, Michael; He, Qi; Afdhal, Nezam; Nunes, David; Fleming, Catherine; Horsburgh, Robert; Craven, Donald; Sherman, Kenneth E; Koziel, Margaret James 2004. Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology (Baltimore, Md.), 40 1, 125-32

Keenan, Erica D; Rouster, Susan D; Shire, Norah J; Horn, Paul S; Sherman, Kenneth E 2004. Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain. The Journal of infectious diseases, 190 3, 511-4

Morelli, Michael S; Rouster, Susan D; Giannella, Ralph A; Sherman, Kenneth E 2004. Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2 8, 669-74

Neff, G W; Sherman, K E; Eghtesad, B; Fung, J 2004. Review article: current status of liver transplantation in HIV-infected patients. Alimentary pharmacology & therapeutics, 20 10, 993-1000

Sherman, Kenneth E 2004. HCV and HIV: a tale of two viruses. Reviews in gastroenterological disorders, 4 Suppl 1 , S48-54

Sherman, Kenneth E; Sherman, Susan N; Chenier, Thomas; Tsevat, Joel 2004. Health values of patients with chronic hepatitis C infection. Archives of internal medicine, 164 21, 2377-82

Shire, Norah J; Rouster, Susan D; Rajicic, Natasa; Sherman, Kenneth E 2004. Occult hepatitis B in HIV-infected patients. Journal of acquired immune deficiency syndromes (1999), 36 3, 869-75

Zucker, Stephen D; Horn, Paul S; Sherman, Kenneth E 2004. Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology (Baltimore, Md.), 40 4, 827-35

Zucker, Stephen D; Sherman, Kenneth E 2004. Beyond interferon for hepatitis C: living in the present while hoping for the future. Gastroenterology, 126 5, 1487-8

Keiserman, Daniela R; Both, Cristiane T; Mattos, Angelo A; Remiao, Jose; Alexandre, Claudio O P; Sherman, Kenneth E 2003. Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection. The American journal of gastroenterology, 98 4, 878-83

Sherman, Kenneth E 2003. Implications of peginterferon use in special populations infected with HCV. Seminars in liver disease, 23 Suppl 1 , 47-52

Shiramizu, Bruce; Theodore, Dickens; Bassett, Roland; Coel, Marc; Sherman, Kenneth E; Glesby, Marshall J; Chow, Dominic; Alston, Beverly; Colquhoun, Dodi; Merigan, Thomas C; Reichman, Richard C; Berggren, Ruth; Burning, Wendy Jo; Brobst, Susan 2003. Correlation of single photon emission computed tomography parameters as a noninvasive alternative to liver biopsies in assessing liver involvement in the setting of HIV and hepatitis C virus coinfection: a multicenter trial of the Adult AIDS Clinical Trials Group. Journal of acquired immune deficiency syndromes (1999), 33 3, 329-35

Ajayi, Thomas; Sherman, Kenneth; Tang, Qisheng 2002. Support of marine sustainability science. Science (New York, N.Y.), 297 5582, 772

Bleau, Brian L; Gostout, Christopher J; Sherman, Kenneth E; Shaw, Michael J; Harford, William V; Keate, Ray F; Bracy, Waldo P; Fleischer, David E 2002. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointestinal endoscopy, 56 1, 1-6

Chung, Raymond T; Evans, Scott R; Yang, Yijun; Theodore, Dickens; Valdez, Hernan; Clark, Rebecca; Shikuma, Cecilia; Nevin, Thomas; Sherman, Kenneth E 2002. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS (London, England), 16 14, 1915-23

Goedert, James J; Eyster, M Elaine; Lederman, Michael M; Mandalaki, Titica; De Moerloose, Philippe; White, Gilbert C; Angiolillo, Anne L; Luban, Naomi L C; Sherman, Kenneth E; Manco-Johnson, Marilyn; Preiss, Liliana; Leissinger, Cindy; Kessler, Craig M; Cohen, Alan R; DiMichele, Donna; Hilgartner, Margaret W; Aledort, Louis M; Kroner, Barbara L; Rosenberg, Philip S; Hatzakis, Angelos 2002. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood, 100 5, 1584-9

Sherman, Kenneth E 2002. Diagnosis and management of the HCV/HIV-coinfected patient. AIDS clinical care, 14 5, 39-43, 48

Sherman, Kenneth E; Rouster, Susan D; Chung, Raymond T; Rajicic, Natasa 2002. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 6, 831-7

Sherman, Kenneth E; Rouster, Susan D; Horn, Paul S 2002. Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 35 4, 482-7

Sherman, K E; Rouster, S D; Feinberg, J 2001. Prevalence and genotypic variability of TTV in HIV-infected patients. Digestive diseases and sciences, 46 11, 2401-7

Zucker, S D; Qin, X; Rouster, S D; Yu, F; Green, R M; Keshavan, P; Feinberg, J; Sherman, K E 2001. Mechanism of indinavir-induced hyperbilirubinemia. Proceedings of the National Academy of Sciences of the United States of America, 98 22, 12671-6

Manocha, A P; Sossenheimer, M; Martin, S P; Sherman, K E; Venkatesan, T; Whitcomb, D C; Ulrich, C D 1999. Prevalence and predictors of severe acute pancreatitis in patients with acquired immune deficiency syndrome (AIDS). The American journal of gastroenterology, 94 3, 784-9

Mendenhall, C L; Finkelman, F; Means, R T; Sherman, K E; Nguyen, V T; Grossman, C E; Morris, S C; Rouster, S; Roselle, G A 1999. Cytokine response to BCG infection in alcohol-fed mice. Alcohol (Fayetteville, N.Y.), 19 1, 57-63

Sherman, K E; Rouster, S D; Mendenhall, C; Thee, D 1999. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Hepatology (Baltimore, Md.), 30 1, 265-70

Sherman, K E; Sickler, J; Aranda-Michel, J; Weber, F L; Martin, S; Whiting, J; Hanto, D 1999. Rimantadine for treatment of hepatitis C infection in liver transplant recipients. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 5 1, 25-8

Aranda-Michel, J; Sherman, K E 1998. Tests of the liver: use and misuse. The Gastroenterologist, 6 1, 34-43

Sherman, K E; Sjogren, M; Creager, R L; Damiano, M A; Freeman, S; Lewey, S; Davis, D; Root, S; Weber, F L; Ishak, K G; Goodman, Z D 1998. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial. Hepatology (Baltimore, Md.), 27 4, 1128-35

Sickler, J B; Simmons, R A; Cobb, D K; Sherman, K E 1998. Cutaneous necrosis associated with interferon alpha-2b. The American journal of gastroenterology, 93 3, 463-4

Sherman, K E; Mendenhall, C; Thee, D L; O'Brien, J; Rouster, S D 1997. Hepatitis C serotypes in nonalcoholic and alcoholic patients. Digestive diseases and sciences, 42 11, 2285-91

Jain, R; McLaren, B; Bejarano, P; Sherman, K E 1996. A 69-year-old man with cholestatic liver disease. Seminars in liver disease, 16 4, 445-9

Sherman, K E; Andreatta, C; O'Brien, J; Gutierrez, A; Harris, R 1996. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology (Baltimore, Md.), 23 4, 688-94

Sherman, K E; Lewey, S M; Goodman, Z D 1995. Talc in the liver of patients with chronic hepatitis C infection. The American journal of gastroenterology, 90 12, 2164-6

Younossi Z.M.; Ratziu V.; Loomba R.; Rinella M.; Anstee Q.M.; Goodman Z.; Bedossa P.; Geier A.; Beckebaum S.; Newsome P.N.; Sheridan D.; Sheikh M.Y.; Trotter J.; Knapple W.; Lawitz E.; Abdelmalek M.F.; Kowdley K.V.; Montano-Loza A.J.; Boursier J.; Mathurin P.; Bugianesi E.; Mazzella G.; Olveira A.; Cortez-Pinto H.; Graupera I.; Orr D.; Gluud L.L.; Dufour J.F.; Shapiro D.; Campagna J.; Zaru L.; MacConell L.; Shringarpure R.; Harrison S.; Sanyal A.J.; Abdelmalek M.; Abrams G.; Aguilar H.; Ahmed A.; Aigner E.; Aithal G.; Ala A.; Alazawi W.; Albillos A.; Allison M.; Al-Shamma S.; Andrade R.; Andreone P.; Angelico M.; Ankoma-Sey V.; Anstee Q.; Anty R.; Araya V.; Arenas Ruiz J.I.; Arkkila P.; Arora M.; Asselah T.; Au J.; Ayonrinde O.; Bailey R.J.; Balakrishnan M.; Bambha K.; Bansal M.; Barritt S.; Bate J.; Beato J.; Behari J.; Bellot P.; Ben Ari Z.; Bennett M.; Berenguer M.; Beretta-Piccoli B.T.; Berg T.; Bonacini M.; Bonet L.; Borg B.; Bourliere M.; Bowman W.; Bradley D.; Brankovic M.; Braun M.; Bronowicki J.P.; Bruno S.; Cai C.; Calleja Panero J.L.; Carey E.; Carmiel M.; Carrión J.A.; Cave M.; Chagas C.; Chami T.; Chang A.; Coates A.; Cobbold J.; Corey K.; Corless L.; Crespo J.; Cruz Pereira O.; de Ledinghen V.; deLemos A. 12-14-2019. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multice The Lancet, 394 10215, 2184-2196

Bejarano P.; Koehler A.; Sherman K. 12-10-2001. Second opinion pathology in liver biopsy interpretation American Journal of Gastroenterology, 96 11, 3158-3164

Shire N.; Sherman K. 12-01-2006. Hepatitis B genotype C subgroups in Asia: Are they clinically relevant? Contagion: Reports, Cases, and Commentaries in HIV and Infectious Disease Research, 3 1, 15-17

Bodurka-Bevers D.; Dennis D.T.; Kaliner M.A.; Kopans D.B.; Sherman K.E. 12-01-2000. Five diagnostic controversies Patient Care, 34 3, 179-205

Soriano V.; Sherman K.; Rockstroh J.; Dieterich D.; Back D.; Sulkowski M.; Peters M. 11-28-2011. Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected p AIDS, 25 18, 2197-2208

Goedert J.; Hatzakis A.; Sherman K.; Eyster M. 11-01-2001. Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in p Journal of Infectious Diseases, 184 9, 1202-1205

Abu Dayyeh B.; Gupta N.; Sherman K.; de Bakker P.; Chung R. 10-07-2011. Il28b alleles exert an additive dose effect when applied to HCV-HIV coinfected persons undergoing pe PLoS ONE, 6 10,

Zucker S.; Benedict M.; Sherman K. 10-01-2006. Serum bilirubin and risk of colorectal cancer [1] Alimentary Pharmacology and Therapeutics, 24 8, 1257-1259

Sherman K.; Flamm S.; Afdhal N.; Nelson D.; Sulkowski M.; Everson G.; Fried M.; Adler M.; Reesink H.; Martin M.; Sankoh A.; Adda N.; Kauffman R.; George S.; Wright C.; Poordad F. 09-15-2011. Response-guided telaprevir combination treatment for hepatitis C virus infection New England Journal of Medicine, 365 11, 1014-1024

Masur H.; Kaplan J.E.; Holmes K.K.; Alston B.; Alter M.J.; Ampel N.; Anderson J.R.; Baker A.C.; Barr D.; Bartlett J.G.; Bennett J.E.; Benson C.A.; Bower W.A.; Bozzette S.A.; Brooks J.T.; Cargill V.A.; Castro K.G.; Chaisson R.E.; Cooper D.; Crumpacker C.S.; Currier J.S.; DeCock K.M.; Deyton L.; Dowell S.F.; Drew W.L.; Duncan W.R.; Dworkin M.S.; Dykewicz C.; Eisinger R.W.; Ellerbrock T.; El-Sadr W.; Feinberg J.; Freedberg K.A.; Fukuda K.; Furrer H.; Gatell J.M.; Gnann J.W.; Goldberger M.J.; Goldie S.; Goosby E.P.; Gordin F.; Gross P.A.; Hajjeh R.; Hafner R.; Havlir D.; Holmberg S.; Holtgrave D.R.; Hooton T.M.; Jabs D.A.; Jacobson M.A.; Jaffe H.; Janoff E.; Jones J.; Juranek D.D.; Kitahata M.; Kovacs J.A.; Leport C.; Levin M.J.; Lopez J.C.; Lundgren J.; Marco M.; Mast E.; Mayers D.; Mofenson L.M.; Montaner J.S.G.; Moore R.; Navin T.; Neaton J.; Nelson C.; O'Neill J.F.; Palefsky J.; Pau A.; Pellett P.; Phair J.P.; Piscitelli S.; Polis M.A.; Quinn T.C.; Reeves W.C.; Reiss P.; Rimland D.; Schuchat A.; Sears C.L.; Seeff L.; Sepkowitz K.A.; Sherman K.E.; Slama T.G.; Sloand E.M.; Spector S.A.; Stewart J.A.; Thomas D.L.; Uyeki T.M.; Van Dyke R.B.; Villarino M.E.; Wald A.; Watts D.H.; Wheat L.J.; Williams P.; Wright T.C. 09-03-2002. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 Annals of Internal Medicine, 137 5 II, 435-477

Chung R.T.; Davis G.L.; Jensen D.M.; Masur H.; Saag M.S.; Thomas D.L.; Aronsohn A.I.; Charlton M.R.; Feld J.J.; Fontana R.J.; Ghany M.G.; Godofsky E.W.; Graham C.S.; Kim A.Y.; Kiser J.J.; Kottilil S.; Marks K.M.; Martin P.; Mitruka K.; Morgan T.R.; Naggie S.; Raymond D.; Reau N.S.; Schooley R.T.; Sherman K.E.; Sulkowski M.S.; Vargas H.E.; Ward J.W.; Wyles D.L. 09-01-2015. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected Hepatology, 62 3, 932-954

Butt A.; Umbleja T.; Andersen J.; Sherman K.; Chung R. 09-01-2012. Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in he Clinical Infectious Diseases, 55 5, 631-638

Chak E.; Talal A.; Sherman K.; Schiff E.; Saab S. 09-01-2011. Hepatitis C virus infection in USA: An estimate of true prevalence Liver International, 31 8, 1090-1101

Goedert J.J.; Siegel J.; Miller K.; Lederman M.M.; Thompson A.; Browning B.; Gamerman S.; McRedmond K.; Withycombe J.; Gruppo R.; Stack G.; Lusher J.; Percy L.; Nugent D.; McDaniel M.; Manno C.; Butler R.; Wade A.; Angiolillo A.; Luban N.L.C.; Guelcher C.; Tarantino M.; Greer S.; Gill J.; Nelson J.; White G.; Fried M.; Grimsley A.L.; DiMichele D.; Goldberg I.; French J.; Hibner S.; Steinberg J.; Faust S.; Key N.; Hannemann V.; Kessler C.M.; Lee A.E.; Eyster M.E.; Galli K.; Jenkins G.; Bernstein Z.P.; Belling L.; Shapiro A.; Halley M.; Noblet P.; Jardine L.; Laudenbach L.; Lipton R.; Pece C.; Leissinger C.A.; Schmidt C.; Carr M.; Nolte M.; Manco-Johnson M.; Giambartolomei S.; Rubin S.H.; Belliveau D.; Aledort L.; McCarthy J.; Lemons R.; Bleak S.; Kraut E.; Witkoff L.; Sexauer C.; Kiplinger F.; Thompson A.; Cooper C.; Britton H.; Cobb K.; Reimers H.J.; Bagato J.A.; Powell J.S.; Herr M.; Scott K.; Hutter J.; Damiano M.L.; Navarro W.; Roth J.; Palascak J.; Sherman K.; Heffner M.; DiPaolo J.; Lammer M.; Iyer R.; Matthew P.; Schwartz M.; Konkle B.; Vijayanathan N.; Dugdale M.; Lilley D.; Hoots K.; Brown D.; Ullman M.; Neff A.; Klintworth S.; Sabio H.; Smith A.; Karafoulidou A. 09-01-2005. Prevalence of conditions associated with human immunodeficiency and hepatits virus infections among Haemophilia, 11 5, 516-528

Theodore D.; Fried M.W.; Kleiner D.E.; Kroner B.L.; Goedert J.J.; Eyster M.E.; Faust S.P.; Sherman K.E.; Kessler C.M.; Francis C.; Aledort L.M. 09-01-2004. Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C Haemophilia, 10 5, 413-421

Eckman M.H.; Woodle E.S.; Thakar C.V.; Paterno F.; Sherman K.E. 08-21-2018. Kidney transplants for patients with hepatitis C virus infection Annals of Internal Medicine, 169 4, I16

Eckman M.H.; Woodle E.S.; Thakar C.V.; Paterno F.; Sherman K.E. 08-21-2018. Correction: Glycemic targets for older adults with type 2 diabetes (Annals of Internal Medicine (201 Annals of Internal Medicine, 169 12, 899

Murrison L.; Sherman K. 08-01-2017. The enigma of Hepatitis e Virus Gastroenterology and Hepatology, 13 8, 484-491

Kemmer N.; Sherman K. 07-24-2008. What is the impact of HIV infection on survival after liver transplantation? Commentary Nature Clinical Practice Gastroenterology and Hepatology, 5 8, 426-427

Sulkowski M.S.; Sherman K.E.; Dieterich D.T.; Bsharat M.; Mahnke L.; Rockstroh J.K.; Gharakhanian S.; Mccallister S.; Henshaw J.; Girard P.M.; Adiwijaya B.; Garg V.; Rubin R.A.; Adda M.; Soriano V. 07-16-2013. Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients w Annals of Internal Medicine, 159 2, 86-96

Ragni M.; Sherman K.; Jordan J. 07-01-2010. Viral pathogens Haemophilia, 16 SUPPL. 5, 40-46

Khalsa J.; Kresina T.; Sherman K.; Vocci F. 07-01-2005. Medical management of HIV-hepatitis C virus coinfection in injection drug users Clinical Infectious Diseases, 41 1 SUPPL.,

Terrault N.; Roland M.; Schiano T.; Dove L.; Wong M.; Poordad F.; Ragni M.; Barin B.; Simon D.; Olthoff K.; Johnson L.; Stosor V.; Jayaweera D.; Fung J.; Sherman K.; Subramanian A.; Millis J.; Slakey D.; Berg C.; Carlson L.; Ferrell L.; Stablein D.; Odim J.; Fox L.; Stock P. 06-01-2012. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectio Liver Transplantation, 18 6, 716-726

Neff G.; Jayaweera D.; Sherman K. 06-01-2006. Drug-induced liver injury in HIV patients Gastroenterology and Hepatology, 2 6, 430-437

Root S.; DeAngelis S.; Sherman K. 06-01-1996. Preliminary evaluation of an automated device for percutaneous liver biopsy Journal of Clinical Gastroenterology, 22 4, 325-326

Eckman M.; Talal A.; Gordon S.; Schiff E.; Sherman K. 05-15-2013. Cost-effectiveness of screening for chronic hepatitis C infection in the United States Clinical Infectious Diseases, 56 10, 1382-1393

Eyster M.E.; Sherman K.E.; Goedert J.J.; Katsoulidou A.; Hatzakis A. 05-05-1999. Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia Journal of Infectious Diseases, 179 5, 1062-1069

Hu K.Q.; Cui W.; Rouster S.D.; Sherman K.E. 05-01-2019. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfectio World Journal of Hepatology, 11 5, 442-449

Coffin C.; Stock P.; Dove L.; Berg C.; Nissen N.; Curry M.; Ragni M.; Regenstein F.; Sherman K.; Roland M.; Terrault N. 05-01-2010. Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant reci American Journal of Transplantation, 10 5, 1268-1275

Shire N.; Sherman K. 05-01-2006. Vaccination against hepatitis A and B in patients with HIV Current Hepatitis Reports, 5 2, 63-67

Lempicki R.; Polis M.; Yang J.; McLaughlin M.; Koratich C.; Huang D.; Fullmer B.; Wu L.; Rehm C.; Masur H.; Lane H.; Sherman K.; Fauci A.; Kottilil S. 04-15-2006. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: Class prediction analyses b Journal of Infectious Diseases, 193 8, 1172-1177

Thomas D.; Bartlett J.; Peters M.; Sherman K.; Sulkowski M.; Pham P. 04-01-2012. Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis Clinical Infectious Diseases, 54 7, 979-983

Sherman K. 04-01-2005. Special considerations in the management of HIV/HCV coinfection Advanced Studies in Medicine, 5 4 C,

Ryen R.; Friedman L.; Gress F.; Kaplan L.; Katz P.O.; Ouyang A.; Richter J.; Rosen H.; Sherman K.; Feldman M.; Lee S.P.; Banks P.F.; Richard Boland C.; Ahnen D.J.; Burt R.W.; Itzkowitz S.H.; Bass N.M.; Brown R.; Stevens P.; Klein S.; Aranda-Michel J.; Buchman A.; Floch M.; Heizer W.; Winter H.; Scharschmidt B.F.; Brenner D.A.; Hoofnagle J.H.; Hulley S.B.; Lieberman D.A.; Peura D.A.; Benya R.V.; McGuigan J.E.; Rao M.C.; Sternini C.; Valentine J.F.; Hall K.E.; Attar B.; Holt P.; Lee M.; Prather C.; Proctor D.D.; Anderson J.M.; Fisher R.M.L.; Wolf J.L. 04-01-2003. Training the gastroenterologist of the future: The gastroenterology core curriculum Gastroenterology, 124 4, 1055-1104

Poordad F.; McCone J.; Bacon B.R.; Bruno S.; Manns M.P.; Sulkowski M.S.; Jacobson I.M.; Reddy K.R.; Goodman Z.D.; Boparai N.; DiNubile M.J.; Sniukiene V.; Brass C.A.; Albrecht J.K.; Bronowicki J.P.; Colombato L.; Curciarello J.; Silva M.; Tanno H.; Terg R.; Adler M.; Langlet P.; Lasser L.; Nevens F.; Anderson F.; Bailey R.; Bilodeau M.; Cooper C.; Feinman S.V.; Heathcote J.; Levstik M.; Ramji A.; Sherman M.; Shafran S.; Yoshida E.; Achim A.; Ben Ali S.; Bigard M.A.; Bonny C.; Bourliere M.; Boyer-Darrigrand N.; Canva V.; Couzigou P.; De Ledinghen V.; Guyader D.; Hezode C.; Larrey D.; Latournerie M.; Marcellin P.; Mathurin P.; Maynard-Muet M.; Moussalli J.; Poupon R.; Poynard T.; Serfaty L.; Tran A.; Trepo C.; Truchi R.; Zarski J.P.; Berg T.; Dikopoulos N.; Eisenbach C.; Galle P.R.; Gerken G.; Goeser T.; Gregor M.; Klass D.; Kraus M.R.; Niederau C.; Schlaak J.F.; Schmid R.; Thies P.; Schmidt K.; Thimme R.; Weidenbach H.; Zeuzem S.; Angelico M.; Carosi G.; Craxì A.; Mangia A.; Pirisi M.; Rizzetto M.; Taliani G.; Zignego A.L.; Reesink H.W.; Serejo F.; Reymunde A.; Rosado B.; Torres E.; Barcena Marugan R.; De La Mata M.; Calleja J.L.; Castellano G.; Diago M.; Esteban R.; Fernandez-Rodriguez C.; Sanchez Tapias J.; Serra Desfilis M.A.; Afdhal N.; Al-Osaimi A. 03-31-2011. Boceprevir for untreated chronic HCV genotype 1 infection New England Journal of Medicine, 364 13, 1195-1206

Sherman K. 03-01-2006. Hepatitis C virus coinfection and other hepatic complications in HIV treatment Advanced Studies in Medicine, 6 3 B,

Seth A.; Sherman K.E. 02-01-2020. Hepatitis E: What We Think We Know Clinical Liver Disease, 15 S1, S37-S44

Zhang M.; O'Brien T.R.; Kopp W.C.; Goedert J.J.; Rosenberg P.S.; Rabkin C.S.; Engels E.A.; Whitby D.; Eyster M.E.; Konkle B.; Manco-Johnson M.; DiMichele D.; Hilgartner M.W.; Blatt P.; Aledort L.M.; Seremetes S.; Hoots K.; Angiolillo A.L.; Luban N.L.C.; Cohen A.; Manno C.S.; Leissinger C.; White G.C.; Lederman M.M.; Purvis S.; Salkowitz J.; Kessler C.M.; Karafoulidou A.; Mandalaki T.; Hatzakis A.; Touloumi G.; Schramm W.; Rommel F.; de Moerloose P.; Eichinger S.; Sherman K.E.; Kroner B.L. 01-18-2005. Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human imm BMC Blood Disorders, 5 ,

Gentene A.J.; Bell A.M.; Pence A.; Thomas K.; Jakubecz C.; Stacy E.; Woolf B.; Guido M.R.; Mueller E.W.; Sherman K.E. 01-01-2020. Sustained Virological Response of Patients Hospitalized Compared With Those Not Hospitalized During Annals of Pharmacotherapy, ,

Tamargo J.A.; Campa A.; Martinez S.S.; Li T.; Sherman K.E.; Zarini G.; Meade C.S.; Mandler R.N.; Baum M.K. 01-01-2020. Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies Journal of Psychoactive Drugs, ,

Sherman K.E.; Kang M.; Sterling R.; Umbleja T.; Marks K.; Kiser J.J.; Alston-Smith B.; Greaves W.; Butt A.A. 01-01-2017. Phase 3 trial of first generation protease inhibitor therapy for hepatitis c virus/human immunodefic World Journal of Hepatology, 9 4, 217-223

Anwar N.; Sherman K.E. 01-01-2014. HCV treatment of special populations: HIV coinfected, liver transplant, and renal failure Clinical Liver Disease, 4 4, 80-83

Ragni M.; Devera M.; Roland M.; Wong M.; Stosor V.; Sherman K.; Hardy D.; Blumberg E.; Fung J.; Barin B.; Stablein D.; Stock P. 01-01-2013. Liver transplant outcomes in HIV(+) haemophilic men Haemophilia, 19 1, 134-140

Soriano V.; Barreiro P.; Sherman K.E. 01-01-2013. The changing epidemiology of liver disease in HIV patients AIDS Reviews, 15 1, 25-31

Sherman K.E. 01-01-2012. Preface HIV and Liver Disease, , v-vi

Sherman K.E. 01-01-2012. HIV and liver disease HIV and Liver Disease, , 1-209

Goedert J.J.; Brown D.L.; Hoots K.; Sherman K.E. 01-01-2004. Human immunodeficiency and hepatitis virus infections and their associated conditions and treatments Haemophilia, Supplement, 10 4, 205-210

Goedert J.J.; Goedert J.J.; Hatzakis A.; Maloney E.M.; Eyster M.E.; O’Brien T.R.; Rosenberg P.S.; Rabkin C.S.; Engels E.A.; Hisada M.; Maloney E.; Gail M.H.; O’Brien S.J.; Dean M.; Carrington M.; Smith M.; Winkler C.; Eyster M.E.; Konkle B.; Manco-Johnson M.; Di Michele D.; Hilgartner M.W.; Blatt P.; Aledort L.M.; Seremetes S.; Hoots K.; Angiolillo A.L.; Luban N.L.C.; Cohen A.; Manno C.S.; Leissinger C.; White G.C.; Lederman M.M.; Purvis S.; Salkowitz J.; Kessler C.M.; Karafoulidou A.; Mandalaki T.; Hatzakis A.; Touloumi G.; Schramm W.; Rommel F.; de Moerloose P.; Eichinger S.; Sherman K.E.; Whitby D.; Waters D.; Lamprecht V.; Kroner B.L. 01-01-2000. Increased liver decompensation risk with atypical hepatitis C virus antibody levels Journal of Infectious Diseases, 182 2, 590-594

Bessesen M.; Ives D.; Condreay L.; Lawrence S.; Sherman K. 01-01-1999. Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following Clinical Infectious Diseases, 28 5, 1032-1035

Sudduth R.; DeAngelis S.; Sherman K.; McNally P. 01-01-1995. The effectiveness of simethicone in improving visibility during colonoscopy when given with a sodium Gastrointestinal Endoscopy, 42 5, 413-415

Lawrence S.; Sherman K.; Lawson J.; Goodman Z. 01-01-1994. A 39 year old man with chronic hepatitis Seminars in Liver Disease, 14 1, 97-105

Sherman K.; Creager R.; O'Brien J.; Sargent S.; Piacentini S.; Thieme T. 01-01-1994. The use of oral fluid for hepatitis C antibody screening American Journal of Gastroenterology, 89 11, 2025-2027

Sherman K.E.; Narkewicz M.; Pinto P.C. 01-01-1994. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatiti Journal of Hepatology, 21 6, 1040-1047

Sherman K.E.; O'Brien J.; Gutierrez A.G.; Harrison S.; Urdea M.; Neuwald P.; Wilber J. 01-01-1993. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency Journal of Clinical Microbiology, 31 10, 2679-2682

Sherman K.; Goodman Z. 01-01-1992. End-stage liver disease in a 31-year-old man Seminars in Liver Disease, 12 3, 340-344

Sherman K.; Jones C. 01-01-1992. Hepatotoxicity associated with piroxicam use Gastroenterology, 103 1, 354-355

Sherman K.E.; Freeman S.; Harrison S.; Andron L. 01-01-1991. Prevalence of antibody to hepatitis c virus in patients infected with the human immunodeficiency vir Journal of Infectious Diseases, 163 2, 414-415

Sherman K.E.; Jones C.C.; Goldstein A.L.; Naylor P.H. 01-01-1991. Low thymosin alpha-1 concentrations in patients chronically infected with the hepatitis B virus Viral Immunology, 4 3, 195-199

Acquavita, Shauna P; Kauffman, Sandra S; Talks, Alexandra; Sherman, Kate . Pregnant women with substance use disorders: The intersection of history, ethics, and advocacy. Social work in health care, 55 10, 843-860

Lienesch, D W; Sherman, K E; Metzger, A; Shen, G Q . Anti-Clq antibodies in patients with chronic hepatitis C infection. Clinical and experimental rheumatology, 24 2, 183-5

Meyer, C A; White, C S; Sherman, K E . Diseases of the hepatopulmonary axis. Radiographics : a review publication of the Radiological Society of North America, Inc, 20 3, 687-98

Sherman, Kenneth E . Management of the Hepatitis B Virus/HIV-Coinfected Patient. Topics in antiviral medicine, 23 3, 111-4

Sherman, Kenneth E . Managing adverse effects and complications in completing treatment for hepatitis C virus infection. Topics in antiviral medicine, 20 4, 125-8

Sherman, Kenneth E . Advanced liver disease: what every hepatitis C virus treater should know. Topics in antiviral medicine, 19 3, 121-5